This workshop will provide the audience with an overview of the key systems which have been mentioned by FDA inspectors as major areas of concern in FDA regulated pharma laboratories.
Course Description:
This workshop will provide the audience with an overview of the key systems which have been mentioned by FDA inspectors as major areas of concern in FDA regulated pharma laboratories. The topics addressed will include FDA requirements for OOS investigations, equipment program, pharmaceutical and biologics stability programs, method validation and handling regulatory inspections. During the discussion of each of the areas listed below, the workshop participants will work through a series of related FDA 483s to fully understand FDA expectations and the errors which lead to the 483s.
FDA requirements for the equipment program
Equipment qualification
Equipment operation and maintenance
FDA requirements for pharmaceutical and biologics stability programs
Overview of ICH and WHO requirements for stability programs
What are the stability study requirements for Phase I, Phase II and Phase III clinical studies
Stability methods and specifications
483s related to stability programs and lessons learned
Note: Use coupon code 232082 and get 10% off on registration
Course Description:
This workshop will provide the audience with an overview of the key systems which have been mentioned by FDA inspectors as major areas of concern in FDA regulated pharma laboratories. The topics addressed will include FDA requirements for OOS investigations, equipment program, pharmaceutical and biologics stability programs, method validation and handling regulatory inspections. During the discussion of each of the areas listed below, the workshop participants will work through a series of related FDA 483s to fully understand FDA expectations and the errors which lead to the 483s.
FDA requirements for the equipment program
Equipment qualification
Equipment operation and maintenance
FDA requirements for pharmaceutical and biologics stability programs
Overview of ICH and WHO requirements for stability programs
What are the stability study requirements for Phase I, Phase II and Phase III clinical studies
Stability methods and specifications
483s related to stability programs and lessons learned
Note: Use coupon code 232082 and get 10% off on registration